CANCER GENOMICS SERVICES

The integration of Artificial Intelligence (AI) and Machine Learning (ML) into cancer genomics is revolutionizing precision oncology by enabling scalable, accurate, and clinically actionable analysis of complex genomic data. ArrayGen offers AI‑empowered cancer genomics services that turn raw sequencing data into actionable clinical insights. With automated pipelines for germline & somatic variant detection, rich annotation from leading databases, and expert‐guided interpretation in line with ACMG/AMP standards, we enable precise clinical reporting from assays like WGS, WES, and targeted panels. By integrating transcriptomic and epigenomic data, plus AI/ML‑based prioritization, our cancer genomics platform supports earlier detection, optimal therapy choice, and improved outcomes — especially for underrepresented populations. Quality, reproducibility, and data security form the backbone of all our services.



MVD_analysis

Services at ArrayGen

  • Mutation Detection and Variant Calling
  • Clinical sequencing Data interpretation
  • Somatic variant & germline variant & translocation calling
  • Fusion transcript identification
  • Early Prediction of disease from whole exome/genome NGS Sequencing Data
  • ctDNA (circulating tumor DNA) data analysis
  • Biomarker discovery
  • Driver Mutation Prediction
  • Tumor microenvironment classification and Subtyping
  • Gene Expression & Pathway & RNA-Seq Analysis
  • Prognostic and Survival Modeling
  • Gene Expression & RNA-Seq Analysis
  • Single-Cell Genomics and Spatial Analysis
  • Data Integration and Multi-Omics Fusion
  • TCGA image Analysis
  • Pathological image analysis
  • T and B Cell Receptor (TCR/BCR) sequencing data analysis
  • Detection of Novel translocation breakpoints from DNA-Seq data
  • Copy number variation detection from DNA-Seq data


Why ArrayGen

At ArrayGen Technologies, our values are the foundation of everything we do—from delivering exceptional bioinformatics solutions to empowering scientific progress globally.

EXCELLENCE

We strive for excellence through scientific leadership, collaboration, and a strong focus on quality. Our teams are driven to deliver high impact bioinformatics and big data solutions that push the boundaries of innovation.

INNOVATION

We champion innovation at the intersection of genetics, molecular biology, and data science—developing forward thinking solutions that support a smarter, healthier, and more sustainable world.

QUALITY

With a clientcentric approach and a team of experienced scientists, we ensure every project meets the highest standards. Our personalized, precise solutions consistently exceed expectations.




Ready to get more from data?

Tell us about your objectives. We’ll help get you there.




Explore our tools and database


ArrayGen TGCA Expression Map

TCGA Expression Map is an interactive resource for exploring RNA-seq differential expression across 24 human cancer types, covering 42,461 human genes from the TCGA (The Cancer Genome Atlas) study. This dataset includes RNA-seq data from more than 10,000 cancer patients across multiple tumor types. After careful preprocessing, we performed differential expression analysis using standard differential expression methods, comparing case vs. control samples for each cancer type to generate reliable log2 fold change (log2FC) values.

ArrayGen Heatmap Generator

ArrayGen HeatMap Generator is an online tool for researchers to generate heatmap from RNASeq differential Log2 fold change based on case and control. It also accepts FPKM expression values.

Omics2Biomarker (O2B)

An ML Framework is a machine learning–driven platform for biomarker which identifies DEGs using gene expression data and trains a deep neural network (DNN) for disease classification, and applies SHAP to highlight predictive biomarker genes with insights.